Last reviewed · How we verify
Pneumonia caused by Severe acute respiratory syndrome coronavirus 2
Approved treatments
- Olumiant · Eli Lilly
- Olumiant · NHS Greater Glasgow and Clyde
- Roactemra · Roche
Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation.
Clinical guidelines
- FDA label — any
Baricitinib is indicated for the treatment of hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) due to COVID-19.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 patent landscape — cliff calendar, originator estates, attackable patents
- Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 treatment landscape brief
- Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 treatment updates RSS
Frequently asked questions about Pneumonia caused by Severe acute respiratory syndrome coronavirus 2
What drugs treat Pneumonia caused by Severe acute respiratory syndrome coronavirus 2?
Tracked treatments include Olumiant, Roactemra.
What is the treatment for Pneumonia caused by Severe acute respiratory syndrome coronavirus 2?
Standard treatment for Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 includes Olumiant, Roactemra. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Pneumonia caused by Severe acute respiratory syndrome coronavirus 2?
FDA label publishes guidelines for Pneumonia caused by Severe acute respiratory syndrome coronavirus 2. 1 guideline references tracked.
Related
- Treatment landscape: Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 patent cliff · Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 CI report
- Treatment: Olumiant · Eli Lilly
- Treatment: Olumiant · NHS Greater Glasgow and Clyde
- Treatment: Roactemra · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing